Real-Time Monitoring of Bacterial Infection In Vivo: Development of Bioluminescent Staphylococcal Foreign-Body and Deep-Thigh-Wound Mouse Infection Models
- 1 September 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (9) , 2740-8
- https://doi.org/10.1128/aac.47.9.2740-2748.2003
Abstract
Staphylococcal infections associated with catheter and prosthetic implants are difficult to eradicate and often lead to chronic infections. Development of novel antibacterial therapies requires simple, reliable, and relevant models for infection. Using bioluminescent Staphylococcus aureus, we have adapted the existing foreign-body and deep-wound mouse models of staphylococcal infection to allow real-time monitoring of the bacterial colonization of catheters or tissues. This approach also enables kinetic measurements of bacterial growth and clearance in each infected animal. Persistence of infection was observed throughout the course of the study until termination of the experiment at day 16 in a deep-wound model and day 21 in the foreign-body model, providing sufficient time to test the effects of antibacterial compounds. The usefulness of both animal models was assessed by using linezolid as a test compound and comparing bioluminescent measurements to bacterial counts. In the foreign-body model, a three-dose antibiotic regimen (2, 5, and 24 h after infection) resulted in a decrease in both luminescence and bacterial counts recovered from the implant compared to those of the mock-treated infected mice. In addition, linezolid treatment prevented the formation of subcutaneous abscesses, although it did not completely resolve the infection. In the thigh model, the same treatment regimen resulted in complete resolution of the luminescent signal, which correlated with clearance of the bacteria from the thighs.Keywords
This publication has 29 references indexed in Scilit:
- In Vitro Activities of Quinupristin-Dalfopristin and Cefepime, Alone and in Combination with Various Antimicrobials, against Multidrug-Resistant Staphylococci and Enterococci in an In Vitro Pharmacodynamic ModelAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Evaluation of AZD2563, a Novel Oxazolidinone, against 603 Recent Staphylococcal IsolatesAntimicrobial Agents and Chemotherapy, 2002
- In vitro activity of linezolid, synercid and telithromcin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureusInternational Journal of Antimicrobial Agents, 2002
- Effects of 2 Different Anti–Tumor Necrosis Factor–? Agents in a Primate Model of Subcutaneous Abscess FormationThe Journal of Infectious Diseases, 2002
- Visualizing Pneumococcal Infections in the Lungs of Live Mice Using Bioluminescent Streptococcus pneumoniae Transformed with a Novel Gram-Positive lux TransposonInfection and Immunity, 2001
- The Impact of Hospital-Acquired Bloodstream InfectionsEmerging Infectious Diseases, 2001
- Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of InfectionAntimicrobial Agents and Chemotherapy, 2001
- Monitoring BioluminescentStaphylococcus aureusInfections in Living Mice Using a NovelluxABCDEConstructInfection and Immunity, 2000
- MICROBIAL BIOFILMSAnnual Review of Microbiology, 1995
- A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead.Circulation, 1982